Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world analysis of autologous stem cell transplantation in primary central nervous system lymphoma using Taiwan Blood and Marrow Transplantation Registry.

Journal of the Formosan Medical Association = Taiwan yi zhi·2026
Same author

Mezigdomide, carfilzomib, and dexamethasone versus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma (SUCCESSOR-2): a phase 3, open-label, randomised controlled trial.

Lancet (London, England)·2026
Same author

Thrombocytosis Phenotype in Prefibrotic Primary Myelofibrosis: Risk Stratification and Prognostic Significance.

Clinical lymphoma, myeloma & leukemia·2026
Same author

Classification of hematologic malignancies from whole-slide bone marrow aspirates using a two-stage deep convolutional neural network pipeline.

Digital health·2026
Same author

Speech analysis for differentiating bipolar disorder and major depressive disorder during euthymic states.

Annals of general psychiatry·2026
Same author

Increased Frequency and Distinct Genotypic Patterns of Somatic Aldosterone-Driver Mutations in Aldosterone-Producing Micronodules from Primary Aldosteronism Patients.

Endocrine pathology·2026

Related Experiment Video

Updated: May 8, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Hyperthyroidism and risk for bipolar disorders: a nationwide population-based study.

Li-Yu Hu1, Cheng-Che Shen, Yu-Wen Hu

  • 1Department of Psychiatry, Yuli Veterans Hospital, Hualien, Taiwan.

Plos One
|September 12, 2013
PubMed
Summary

Hyperthyroidism is linked to a higher incidence of bipolar disorders. Women, patients with alcohol use disorders, and those with asthma face increased risk when diagnosed with hyperthyroidism.

Related Experiment Videos

Last Updated: May 8, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Area of Science:

  • Endocrinology
  • Psychiatry
  • Epidemiology

Background:

  • Thyroid disorders, particularly hyperthyroidism, are often associated with psychiatric symptoms like anxiety and depression.
  • The specific risk of developing bipolar disorders in individuals with hyperthyroidism remains under-characterized.

Purpose of the Study:

  • To investigate the association between hyperthyroidism and the subsequent development of bipolar disorders.
  • To identify risk factors for bipolar disorders among patients with hyperthyroidism.

Main Methods:

  • A cohort of 21,574 hyperthyroid patients (2000-2010) was identified from Taiwan's National Health Insurance Research Database.
  • A matched comparison cohort without hyperthyroidism was established based on age, sex, and comorbidities.
  • Bipolar disorder occurrence was assessed through diagnosis and mood stabilizer prescriptions.

Main Results:

  • Hyperthyroidism patients exhibited a significantly higher incidence of bipolar disorders (IRR 2.31, P<.001) compared to controls.
  • Independent risk factors for bipolar disorder in hyperthyroid patients included female sex (HR 2.02, P=.001), alcohol use disorders (HR 3.03, P=.001), and asthma (HR 1.70, P=.004).

Conclusions:

  • This study suggests a potential link between hyperthyroidism and an increased risk of developing bipolar disorders.
  • The findings highlight specific demographic and comorbidity factors that may predispose hyperthyroid patients to bipolar disorders.